Replies to post #110612 on PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Maybe those billion shares are for a partner to buy into the company

Very likely.

Of course a buyin is more likely now trial material is finalized.

Of course ind submission will trigger massive interest.

And kw is 75 years old.

Do you honestly think he would want to spend years more taking this through trials or accept a huge payout and sell his millions of shares for squillions?

Things have changed. The trial material is reproducible. kw has done his job and possibly made a bit along the way. Or others have.

But this is the start of a new chapter.

Ind is ready for submission.

Partnership, funding via buyin or buyout are all very much more likely now.

I say the billion shares and recent urgent shareholder meeting were set ups for a partnership.

And that partnership is subject to a successful ind.

Let’s not forget how valuable a robust encapsulation technology that doesn’t attract fibrosis and Is reproducible is worth. Sigilon was worth 950 million. And it’s alginate and not tested in humans.

Could be a very exciting 2020.

Don’t let people who know kw and may have insider info get cheap shares just before a big announcement.

The people who bought hundreds of millions of cheap shares haven’t sold them all by any means. If they bought them direct from the comlany they may know things we don’t.

[$Pistol Pete$]

So we are begging FDA to use 20 years old data. Is this a joke?